BiopharmaTrend.com

Intellegens

Intellegens

Private company
INTELLEGENS

Intellegens is a spin-out from the University of Cambridge that has developed a unique Artificial Intelligence (AI) method for training neural networks from incomplete data sets. The technique, developed in the Department of Physics, is being applied to drug discovery and material design problems.

We have developed a unique capability to train and predict models from incomplete data. The technology can be used to link large, easy to acquire, databases with small, hard to acquire datasets. Generated models can be used to design, predict and identify errors.

Given a fragmented dataset the algorithm can learn the underlying correlations to estimate the missing knowledge of how candidate drugs act on proteins and therefore help clients to design new drug cocktails to activate the right proteins to cure disease


Founded
2017
Status
Private company
Geography
United Kingdom based
Funding
$0.130 M
Research papers
1

Products

Alchemite™

The Alchemite™ Engine allows for the simple aggregation of csv based data that can be both sparse and noisy, typical …

Read more

Alchemite™ Analytics Platform

The machine learning platform for formulation design. Easily experiment, model, and visualise sparse and noisy real-world data.

Read more

Ichnite™

Ichnite™ is a federated learning platform that helps aggregate models trained on completely separate and private data sources

Read more

Services

No services posted yet


This data is part of our proprietary analytics report:

This service is currently only supported on the desktop screens, please, use this service from your desktop or laptop for correct visualization and functionality

Go to home page